(Q51777950)

title

Adenosquamous carcinoma of the pancreas harbors KRAS2, DPC4 and TP53 molecular alterations similar to pancreatic ductal adenocarcinoma. (English)

1 reference

12 April 2018

0 references

1 reference

adenosquamous carcinoma

1 reference

adenosquamous pancreas carcinoma

inferred from title

1 reference

7

Ralph H Hruban

1 reference

12 April 2018

Charles J Yeo

6

object named as

Charles J Yeo

1 reference

12 April 2018

author name string

Jonathan R Brody

1

1 reference

12 April 2018

Christina L Costantino

2

1 reference

12 April 2018

Magdalena Potoczek

3

1 reference

12 April 2018

Joseph Cozzitorto

4

1 reference

12 April 2018

Peter McCue

5

1 reference

12 April 2018

Agnieszka K Witkiewicz

8

1 reference

12 April 2018

publication date

6 March 2009

1 reference

12 April 2018

1 reference

12 April 2018

volume

22

1 reference

12 April 2018

page(s)

651-659

1 reference

12 April 2018

issue

5

1 reference

12 April 2018

https://scigraph.springernature.com/pub.10.1038/modpathol.2009.15

exact match

0 references

cites work

Immunohistochemical labeling for dpc4 mirrors genetic status in pancreatic adenocarcinomas : a new marker of DPC4 inactivation

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.15

Aberrant methylation of preproenkephalin and p16 genes in pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.15

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.15

7 January 2021

Adenosquamous carcinoma of the pancreas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.15

7 January 2021

Adenosquamous Carcinoma Of The Pancreas: A Clinicopathologic Series Of 25 Cases

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.15

7 January 2021

Absence of E-cadherin expression distinguishes noncohesive from cohesive pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.15

7 January 2021

A comparison between p53 accumulation determined by immunohistochemistry and TP53 mutations as prognostic variables in tumours from breast cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.15

7 January 2021

E-cadherin expression in invasive non-lobular carcinoma of the breast and its prognostic significance.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.15

7 January 2021

Expression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.15

7 January 2021

Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.15

7 January 2021

DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.15

7 January 2021

Overexpression of p53 protein in adenocarcinoma of the pancreas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.15

7 January 2021

The epidermal growth factor receptor in human pancreatic cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.15

7 January 2021

EGF-ERBB signalling: towards the systems level

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.15

7 January 2021

Targeting the HER-kinase axis in cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.15

7 January 2021

Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.15

7 January 2021

Epithelial-to-mesenchymal transition and integrin-linked kinase mediate sensitivity to epidermal growth factor receptor inhibition in human hepatoma cells.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.15

7 January 2021

Loss of homotypic cell adhesion by epithelial-mesenchymal transition or mutation limits sensitivity to epidermal growth factor receptor inhibition

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.15

7 January 2021

Selecting patients for treatment with epidermal growth factor tyrosine kinase inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.15

7 January 2021

Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.15

7 January 2021

Significant difference in p53 and p21 protein immunoreactivity in HPV 16 positive and HPV negative breast carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.15

7 January 2021

DeltaNp63 expression in pancreas and pancreatic neoplasia

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.15

7 January 2021

10.1038/MODPATHOL.2009.15

Identifiers

DOI

1 reference

12 April 2018

1 reference

12 April 2018